Minerva Neurosciences (NERV) Cash & Current Investments (2013 - 2026)
Minerva Neurosciences' Cash & Current Investments came in at $75.27 million for Q2 2026, up 393.6% from $15.25 million a year earlier but down 3.6% from the prior quarter.
Powered by 
Analysis
Minerva Neurosciences (NERV) Cash & Current Investments (2013 - 2026) Analysis & Trends
At the end of FY2025, Minerva Neurosciences' Cash & Current Investments was $82.3 million, up 285.3% from FY2024.
- Cash & Current Investments carries a five-year compound annual growth rate of 26.6% (FY2020 to FY2025).
- Going back by year, Cash & Current Investments was $21.36 million in FY2024 (-47.8%), $40.91 million in FY2023 (+13.4%), $36.09 million in FY2022 (-40.6%) and $60.76 million in FY2021 (+139.6%).
- The five-year range for quarterly Cash & Current Investments is $12.29 million (Q3 2025) to $82.3 million (Q4 2025).
- Year-over-year, Cash & Current Investments has increased for three consecutive quarters, with growth averaging 98.1% over the last eight quarters.
- The fastest year-over-year change in Cash & Current Investments over five years came in Q2 2026 (growth of 393.6%), and the weakest in Q3 2025 (a decline of 53.7%).
- Business Quant data shows NERV's Cash & Current Investments at $78.06 million (Q1 2026), $82.3 million (Q4 2025) and $12.29 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Minerva Neurosciences | 108.62 Mn | -139.30 Mn | - | 75.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 75.27 Mn |
| Mar 31, 2026 | 78.06 Mn |
| Dec 31, 2025 | 82.30 Mn |
| Sep 30, 2025 | 12.29 Mn |
| Jun 30, 2025 | 15.25 Mn |
| Mar 31, 2025 | 17.29 Mn |
| Dec 31, 2024 | 21.36 Mn |
| Sep 30, 2024 | 26.53 Mn |
| Jun 30, 2024 | 30.88 Mn |
| Mar 31, 2024 | 34.82 Mn |
| Dec 31, 2023 | 40.91 Mn |
| Sep 30, 2023 | 46.90 Mn |
| Jun 30, 2023 | 51.80 Mn |
| Mar 31, 2023 | 35.98 Mn |
| Dec 31, 2022 | 36.09 Mn |
| Sep 30, 2022 | 40.22 Mn |
| Jun 30, 2022 | 49.75 Mn |
| Mar 31, 2022 | 54.95 Mn |
| Dec 31, 2021 | 60.76 Mn |
| Sep 30, 2021 | 65.59 Mn |
API Access
Minerva Neurosciences Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NERV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "NERV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NERV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();